Toolkit / Movement disorders
AIMS: Abnormal Involuntary Movement Scale
Twelve-item clinician-rated examination for tardive dyskinesia. Seven body areas are rated 0–4 and summed; three global judgements and two dental questions are recorded alongside but do not count towards the total.
Interpreting the total
| 0 | No abnormal movements rated |
| 1–28 | Movements rated — see TD criteria |
Notes
- The total of items 1–7 (0–28) is useful for tracking change in the same patient. There are no official severity bands for the total.
- Schooler–Kane research criteria for probable tardive dyskinesia: at least moderate (3) movements in one body area, or at least mild (2) movements in two or more areas, after at least 3 months of cumulative antipsychotic exposure, in the absence of another cause. (DSM-IV research criteria shorten the exposure to 1 month in people aged 60 or over.)
- Repeat the AIMS at baseline and at regular intervals (commonly every 6–12 months) for anyone on long-term antipsychotics, and more often in older adults and those at higher risk.
References
- Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Department of Health, Education and Welfare; 1976. Publication ADM 76-338: 534–537.
- Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39(4):486–487.
Developed by the US National Institute of Mental Health; in the public domain.
An educational aid for clinicians, not a substitute for clinical judgement. Scores support, but never replace, a full assessment. Your answers on this page are never stored or sent.
Spotted an error in this scale?
Interpreting the total
| 0 | No abnormal movements rated |
| 1–28 | Movements rated — see TD criteria |
Notes
- The total of items 1–7 (0–28) is useful for tracking change in the same patient. There are no official severity bands for the total.
- Schooler–Kane research criteria for probable tardive dyskinesia: at least moderate (3) movements in one body area, or at least mild (2) movements in two or more areas, after at least 3 months of cumulative antipsychotic exposure, in the absence of another cause. (DSM-IV research criteria shorten the exposure to 1 month in people aged 60 or over.)
- Repeat the AIMS at baseline and at regular intervals (commonly every 6–12 months) for anyone on long-term antipsychotics, and more often in older adults and those at higher risk.
References
- Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Department of Health, Education and Welfare; 1976. Publication ADM 76-338: 534–537.
- Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39(4):486–487.
Developed by the US National Institute of Mental Health; in the public domain.
This is an educational aid for clinicians, not a substitute for clinical judgement. Scores and calculations support, but never replace, a full assessment. All entries were made by the user; the website does not verify them and accepts no responsibility for decisions based on them. Nothing entered on the website is stored or sent.
